COMPASS Pathways Income from Continuous Operations 2019-2025 | CMPS
COMPASS Pathways income from continuous operations from 2019 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| COMPASS Pathways Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-155 |
| 2023 | $-118 |
| 2022 | $-92 |
| 2021 | $-72 |
| 2020 | $-60 |
| 2019 | $-20 |
| 2018 | $-13 |
| COMPASS Pathways Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-38 |
| 2025-03-31 | $-18 |
| 2024-12-31 | $-43 |
| 2024-09-30 | $-39 |
| 2024-06-30 | $-38 |
| 2024-03-31 | $-35 |
| 2023-12-31 | $-33 |
| 2023-09-30 | $-33 |
| 2023-06-30 | $-28 |
| 2023-03-31 | $-24 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-18 |
| 2022-06-30 | $-21 |
| 2022-03-31 | $-21 |
| 2021-12-31 | $-26 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-18 |
| 2021-03-31 | $-13 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-17 |
| 2020-06-30 | |
| 2020-03-31 | $-9 |
| 2019-12-31 | |
| 2019-09-30 | $-6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.441B | $0.000B |
| COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.392B | 26.22 |
| CVS Health (CVS) | United States | $77.939B | 9.69 |
| Elevance Health (ELV) | United States | $61.908B | 8.33 |
| Cencora (COR) | United States | $56.914B | 19.80 |
| DiDi Global (DIDIY) | China | $24.380B | 25.90 |
| Labcorp Holdings (LH) | United States | $21.926B | 17.43 |
| Natera (NTRA) | United States | $18.648B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.073B | 0.00 |
| ICON (ICLR) | Ireland | $13.309B | 12.81 |
| CochLear (CHEOY) | Australia | $13.242B | 0.00 |
| Solventum (SOLV) | United States | $12.668B | 13.41 |
| Medpace Holdings (MEDP) | United States | $12.148B | 32.15 |
| Viatris (VTRS) | United States | $10.493B | 3.60 |
| Revvity (RVTY) | United States | $10.410B | 18.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.827B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.248B | 16.16 |
| HealthEquity (HQY) | United States | $7.882B | 34.53 |
| Avantor (AVTR) | United States | $7.704B | 11.30 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.854B | 32.67 |
| Amplifon S.p.A (AMFPF) | Italy | $3.890B | 21.30 |
| BrightSpring Health Services (BTSG) | United States | $3.430B | 26.16 |
| Sotera Health (SHC) | United States | $3.202B | 18.19 |
| GeneDx Holdings (WGS) | United States | $3.092B | 71.28 |
| Surgery Partners (SGRY) | United States | $2.847B | 37.03 |
| Alignment Healthcare (ALHC) | United States | $2.705B | 0.00 |
| Concentras Parent (CON) | United States | $2.538B | 14.67 |
| Organon (OGN) | United States | $2.514B | 2.67 |
| Progyny (PGNY) | United States | $1.987B | 43.74 |
| Premier (PINC) | United States | $1.786B | 13.56 |
| PACS (PACS) | United States | $1.675B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.607B | 32.14 |
| Ardent Health (ARDT) | United States | $1.475B | 6.29 |
| Establishment Labs Holdings (ESTA) | $1.235B | 0.00 | |
| Teladoc Health (TDOC) | United States | $1.232B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.057B | 8.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.831B | 285.00 |
| Agilon Health (AGL) | United States | $0.751B | 0.00 |
| CareDx (CDNA) | United States | $0.702B | 10.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.667B | 6.25 |
| Performant Healthcare (PHLT) | United States | $0.596B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| LifeMD (LFMD) | United States | $0.561B | 0.00 |
| Nutex Health (NUTX) | United States | $0.494B | 7.48 |
| InnovAge Holding (INNV) | United States | $0.485B | 0.00 |
| So-Young (SY) | China | $0.483B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| Omada Health (OMDA) | $0.459B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.458B | 0.00 |
| SBC Medicals (SBC) | United States | $0.448B | 0.00 |
| Oncology Institute (TOI) | United States | $0.360B | 0.00 |
| Enhabit (EHAB) | United States | $0.334B | 27.50 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.088B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.056B | 0.00 |
| KindlyMD (NAKA) | United States | $0.055B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| ModivCare (MODV) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |